AwesomeCapital
Search This Blog
Wednesday, May 29, 2019
Northland Capital Markets Starts Opiant Pharma (OPNT) at Outperform
Northland Capital Markets analyst Carl Byrnes initiates coverage on Opiant Pharma (NASDAQ:
OPNT
) with a Outperform rating and a price target of $42.
https://www.streetinsider.com/Analyst+Comments/Northland+Capital+Markets+Starts+Opiant+Pharma+%28OPNT%29+at+Market+Perform/15551993.html
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.